|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 胱抑素C与肌酐在确定肾功能风险方面的作用显示文摘血肌酐联合胱抑素c确定估算的肾小球滤过率(estimatedglomerularfiltrationrate,eGFR),能够提高准确性,但其对不同人群慢性肾脏病检测、分期和风险分类的影响尚未确定。最近美国学者报告了一项荟萃分析,比较了胱抑素c与肌酐在确定肾功能风险方面的作用。 | Shlipak MG Matsushita K rnlv J 王建中 | 2013 | 中华肾病研究电子杂志2013，2，5： | 60 |
| 2 | 心血管健康研究中血压轨迹与死亡率、心血管病事件和心力衰竭的关系显示文摘老年人的一般血压轨迹尚未明确,其与临床结局的关系也尚不确定。方法:本研究采用层次聚类分析法来确定心血管健康研究中4067参与者从0~7年重复测量血压值的血压轨迹。然后采用Cox比例风险回归模型评估每种血压轨迹聚类与全因死亡率、 | Smitson CC Scherzer R Shlipak MG Psaty BM Newman AB Sarnak MJ Odden MC Peralta CA 陈云 叶鹏 | 2018 | 中华高血压杂志2018，26，2： | 3 |
| 3 | Hemoglobin Level, Chronic Kidney Disease, and the Risks of Death and Hospitalization in Adults With Chronic Heart Failure: The Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study显示文摘 | Alan S. Go Jingrong Yang Lynn M. Ackerson Krista Lepper Sean Robbins Barry M. Massie Michael G. Shlipak | 2006 | Circulation2006，，23： | 2 |
| 4 | 基于胱抑素C和肌酐估算的肾小球滤过率差异及衰弱和不良结局的相关性显示文摘在之前的研究和实践中,尚未对基于胱抑素C水平估算的肾小球滤过率(estimated glomerular filtration rate,eGFR,eGFR胱抑素)和基于肌酐水平估算的eGFR(eGFR肌酐)之间差异的临床重要性和相关性进行评估。研究者旨在评估这些差异是否包含衰弱的重要信息。研究设计:一项收缩压干预试验(the systolic blood pressure intervention trial,SPRINT)的队列分析。设置与参与者:SPRINT(9 092例)高血压参与者在基线时检测血清肌酐、胱抑素C和衰弱水平。 | 袁源(摘译) 练桂丽(审校) Potok OA Ix JH Shlipak MG Katz R Hawfield AT Rocco MV Ambrosius WT Cho ME Pajewski NM Rastogi A Rifkin DE | 2021 | 中华高血压杂志2021，29，1： | 2 |
| 5 | 慢性肾病患者的心血管死亡风险:传统危险因素和新危险因素的比较 | Shlipak M. G. Fried L. F. Cushman M. 杜媛 | 2005 | 世界核心医学期刊文摘(心脏病学分册)2005，0，11： | 2 |
| 6 | Cystatin C and the risk of death and cardiovascular events among elderly persons 显示文摘 | Shlipak MG Sarnak MJ Katz R | 2005 | N Engl J Med2005，352，20： | 1 |
| 7 | Cytatin C and mortal- ity in elderly persons with heart failure 显示文摘 | Michael G Shlipak MD Mark J | 2005 | J Am Coll Cardiol2005，45，5： | 1 |
| 8 | Cystatin C and the risk ofdeath and cardiovascular events among elderly persons显示文摘 | Shlipak MG Sarnak MJ Katz R | 2005 | N EnglJ Med2005，352，20： | 1 |
| 9 | Cystatin C and the risk of death and cardiovascular events among elderly persons显示文摘 | Shlipak MG Sarnak MJ Katz R | 2005 | Engl J Med2005，352，20： | 1 |
| 10 | Hormone therapy and in-hospital survival afer myocardial infarction in post menopausal women显示文摘 | Shlipak MG Angeja BG Go AS | 2001 | Circulation2001，104，19： | 1 |
| 11 | Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study显示文摘 | Ix JH Shlipak MG Chertow GM | 2007 | Circulation2007，115，2： | 1 |
| 12 | C-reactive protein and ischemia in users and nonusers of beta-blockers and statins: data from the Heart and Soul Study 显示文摘 | Beattie MS Shlipak MG L iu H | 2003 | Circulation2003，107，38： | 1 |
| 13 | Relationship of uric acid with progression of kidney disease 显示文摘 | Chonchol M Shlipak MG Katz R | 2007 | Am J Kidney Dis2007，50，： | 1 |
| 14 | The clinical challenge of cardiore- nal syndrome显示文摘 | Shlipak MG Massie BM | 2004 | Circulation2004，110，12： | 1 |
| 15 | Effect of lovastatin on primary prevention of cardiovascular events in mild CKD and kidney function loss: a post hoc analysis of the Air Force/Texas Coronary Atherosclerosis Prevention Study 显示文摘 | Kendrick J Shlipak MG Targher G | 2010 | Am] Kidney Dis2010，，： | 1 |
| 16 | Kidney function and aortic valve and mitral annular calcification in the Multi-Ethnic Study of Atherosclerosis (MESA)显示文摘 | Ix JH Shlipak MG Katz R | | 0，，03： | 1 |
| 17 | Association of eystatin C with mortality,cardiovascular events,and incident heart failure among persons with coronary heart disease - Data from the Heart and Soul Study显示文摘 | Ix Joachim H Shlipak MG Chertow GM | 2007 | Circulation2007，115，2： | 1 |
| 18 | Estrogen and progestin,lipoprotein(a),and the risk of recurrent coronary heart disease events after menopause显示文摘 | SHLIPAK M G SIMON J A VITTINGHOFF E | 2000 | JAMA2000，283，14： | 1 |
| 19 | Association of cya- tatin C with mortality, cardiovascular event and incident heart failure among persons with coronary heart disease:data from the heart and soul study显示文摘 | Ix JH Shlipak MG Chertow GM | 2007 | Circulation2007，115，： | 1 |
| 20 | Pharmacotherapy for heart failure in patientswith renal Insufficiency显示文摘 | Shlipak MG | 2003 | Ann Intern Med2003，138，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员